Ever wait anxiously for days to get the results of medical tests?  Such periods may eventually become passe as new methods for analyzing blood and other tests increasingly allow quick turnaround times in doctors offices, “rapid clinics,” and even in patients’ homes.

According to a new review of the global “point of care” testing industry released today by Scientia Advisors, a Cambridge, San Francisco strategy consulting firm (yes, my client!)–the market for point-of -care medical tests (those analyzed in close proximity to patients)–is growing at 8 per cent–and even faster for certain types of tests and in the developing world.

Harry Glorikian, Scientia’s managing partner, points out that this growth is fueled in part by a trend toward decentralization of health care—in which testing and treatment are migrating from hospital labs to settings such as emergency rooms, outpatient, doctor’s offices, rapid and urgent care clinics, and homes.

But, he points out,  “companies bringing point-of-care (POC) tests to market must consider not only accuracy, reliability and ease of use, but also the challenges of gaining clinical acceptance and meeting sometimes-onerous regulatory and reimbursement requirements.”

Based on primary and secondary research and proprietary analysis, Scientia projects that the POC testing market, which includes professional and over-the-counter segments, will experience compound annual growth of 8%, from $11.6B in 2008 to $18.4B through 2013 —with additional potential for growth in emerging economies.

While diabetes is the largest segment of the POC testing market, infectious disease testing, a smaller segment, has high growth potential due to (1) increasing awareness of public health problems such as flu, chlamydia and hospital-acquired infections (2) potential availability of disruptive, point-of-care molecular diagnostics and (3) increased adoption of POC testing in emerging markets.

Scientia also found that:

  • While the US is a major influencer in the global POC testing market, the developing world will experience the fastest growth—especially in China and India, where the governments plan to open thousands of rural clinics.
  • In the current economic slowdown, US retail giants such as CVS and Wal-Mart have closed many rapid clinics. As a result, rapid clinics may need new strategies, such as partnering with hospitals, to remain viable.
  • Next-generation, portable, easy-to-use technologies, which promise greater accuracy, convenience and clinical impact, will fuel the growth of many POC segments.
  • Stringent regulatory and reimbursement requirements and a need for pharmaco-economic studies remain barriers to widespread POC adoption in the US and abroad.

Scientia’s review, “The Point-of-Care Diagnostics Market: Growth Drivers and Challenges to Widespread Adoption”, is available for download at no cost at www.scientiaadv.com.

—Anita M. Harris

Harriscom blog is a publication of the  Harris Communications Group is a marketing communications and public relations firm located in Boston, MA.


###

The New York Times doesn’t need me to provide free advertising (I hope!) –but I found today’s business section fabulous for anyone interested in social media and media relations and thought I’d share some of the wealth.

First–David Carr, in The Zeal of a Convert to Twitter writes about  how long-form magazine journalist, Buzz Bissinger,  the author of “Friday Night Lights,” got hooked on twitter… 

Then, there are Noam Cohen’s piece on Wiki Leaks: A Renegade Site, Now Working With the News Media

and Claire Cain Miller and Ashlee Vance on   Bing and Google in a Race for Features .

 Robert Cyran opines on how the growing popularity of the Ipad could present problems for many tech industries in  iPad shift may wreak havoc on parts of tech sector

and Jenna Wortham describes “tumbler,” a blogging platform that sounds like a cross of Facebook, Twitter, and WordPress, and which, supposedly, many media companies are starting to use to promote themselves.  Media Companies Try Getting Social With Tumblr .

There are also articles on the UAR’s attempt to block blackberry messaging unless BB allows government monitoring, there, and  Clarie Miller’s piece,  New Site Aims to Connect Reporters and Publicists , which describes  NewsBasis,  a site on which journalists can get queries to potential sources, which  launched today.

Founded by Darryl Siry, a freelance writer for Wired and a marketing executive,  the new site sounds much like Peter Shankman’s  Help a Reporter Out, (AKA HARO) in that it allows journalists to post questions or search for sources–  asking questions anonymously to avoid tipping off competitors. 

Speaking as former journalist, I can’t imagine giving away ideas, even anonymously–tho fishing in public is certainly easier than digging for sources.

Evidently,  on NewsBasis, sources can also add a footnote to articles across the Web, so when reporters are doing research using their Web browser, a tab will appear indicating that a NewsBasis source has offered a different point of view or corrected a fact.

I hope this wasn’t too much information for one shot…but, hey, it’s the information age, we’re talking about here.  I’ll be interested in seeing how all of this works out.

Anita M. Harris

Anita M. Harris is president of the Harris Communications Group, a marketing communications, media relations and social media firm in Cambridge, MA.

I’ve been working with Instrumentation Laboratory, a Bedford, MA company, to spread the word about its new diagnostic test that helps prevent brain injury in newborns.  Newly cleared by the FDA, it’s first-ever, rapid point-of-care, lab-quality blood test for measuring  total bilirubin (tBili) in neonates.

Bilirubin, a toxin, can, in high amounts, lead to irreversible brain injury in neonates.  The new tBili assay is performed on IL’s GEM Premier 4000 critical care analyzer.    It allows clinicians to receive lab-quality test results in 90 seconds fromwhole blood in the Neonatal Intensive Care Unit (NICU), rather than wait up to an hour for results from the lab, using traditional chemistry methods.    

 During the first few days of life, the body breaks down fetal red blood cells, producing bilirubin.  More bilirubin is produced than the liver can remove, and it remains circulating in the blood. 

This results in jaundice, the most common condition requiring medical attention in newborns, present in approximately 70%.  However, in 8-10% of newborns, jaundice progresses to severe hyperbilirubinemia.  Left untreated, hyperbilirubinemia can quickly evolve into kernicterus, a devastating, irreversible neonatal brain injury. 

IL announced that it had received the FDA clearance for the test on Tuesday, at the annual meeting of the American Association for Clinical Chemistry. For more information,  check out the Instrumentation Laboratory (US) Web site-http://www.instrumentationlaboratory.com/ilus.aspx .

—Anita Harris

HarrisCom Blog is a publication of the Harris Communications Group of Cambridge, MA. We also publish New Cambridge Observer and Ithaca Diaries Blogs.

My client, Scientia Advisors,  has found that the market for certain advanced medical testing methods is poised for accelerated growth.

Scientia, a management consulting firm, recommends that many diagnostics companies reexamine their portfolios and  business models to position themselves for growth.
Immunoassays are laboratory tests used to identify and quantify blood components associated with particular diseases. Immunoassays are a key growth area within in vitro diagnostics (tests conducted in laboratories, as opposed to those carried out in living organisms).

Based on  a review released on June 28, 2010, Scientia Advisors Founding Partner Arshad Ahmed said: “Most current immunoassay technologies focus on detecting one or several proteins in a patient’s blood/serum or other samples.

 “However, novel markers and new technologies that can detect and measure multiple markers simultaneously will become increasingly available in the next several years.”

 Such advanced technologies—already used in diagnosing and treating infectious diseases, cancer, and kidney injury—are faster, more accurate and more cost-effective than many “traditional” tests. As a result, they may command higher prices and are driving growth in the overall immunoassay market.

What is more, for diagnostics players, marketing and business models are changing, according to Ahmed. Pharmaceutical companies are beginning to incorporate diagnostic tests into their sales processes. And certain diagnostics companies are adopting a “sole service provider” model—in which tests are marketed directly to physicians and performed in company-run laboratories.

 In light of these changes, “it is crucial that companies in the diagnostics space re-examine their business strategies in order to compete successfully in the coming years,” Ahmed said.

Review highlights:

  • The $7.7B immunoassay market, which comprises one fifth of the $37B in vitro diagnostics (IVD) market, grew approximately 6% a year between 2005 and 2007. The immunoassay market has since shown 9% compound annual growth — a rate that is expected to continue through 2012, largely due to technology advancements.
  • Growth in the immunoassay market will be driven by the emergence of (1) ultra-sensitive platforms, which enable detection of analytes at minute concentrations; (2) multiplex technologies, which allow simultaneous analysis of multiple compounds and (3) novel biomarkers that increase the accuracy and efficiency of diagnosis or treatment.
  • Emerging economies, such as China’s, are experiencing robust immunoassay market growth.
  • Personalized medicine and new business models such as the bundling of immunoassays with marketed drugs and the sole service provider areare changing industry paradigms.

                                                                               *

Scientia’s study, Strategic Review of Immunoassays: Seeing Beyond the Market Inflection Point”. is available for download at no cost at www.scientiaadv.com.

—Anita M. Harris

Harriscom Blog is a publication of the Harris Communications Group of Cambridge, MA.

Scientia Advisors, based in Boston and San Francisco,  is a management consulting firm specializing in growth strategies for major and emerging companies in health care, life sciences, biotechnology, and nutrition.
 

 

                                                                                  ###

Sorry to read in today’s Boston Globe that both Business Wire and PR Newswire -which are paid to send out press releases–were hornswaggled by a media relations imposter for whom each posted fake stories.

According to Globe reporter Todd Wallach, last week, PR Newswire   sent out a fake press release claiming President Obama had ordered a probe into General Mills.

And on Friday, Business Wire sent a release falsely claiming that Javelin Pharmaceuticals had won a 5-to-4 victory before the Supreme Court with the aid of Justice Clarence Thomas.

In both cases, the releases were rescinded  before they could affect the companies’ stock prices, Wallach reports.

Both  included a New Zealand phone number at the bottom. 

When Wallach called the number,  Matt Reed, a 30-year-old database designer in Auckland told him that he’d sent the General Mills release to discredit President Obama.  And that he’d sent the Javelin release to push Business Wire and other press release companies to step up their security to prevent future hoaxes.

Odd, to say the least–but definitely a cause for concern.  And, Wallach reports, an FBI investigation.

As a media relations professional, I’ve found both Business Wire and PR Newswire (as well as Marketwire) to be above-board and careful–but can see how hoaxes like these can easily be perpetrated by anyone who has a credit card.

 Not sure if paid wire services need to require background checks before posting releases or if I‘d be willing to undergo one…but do think there’s a need for greater scrutiny of press releases–not just by the paid wire services but by bonafide journalistic wire services, as well.

Again, under my media relations hat, I was delighted when, several years ago, the Associate Press ran a press release I sent on behalf of a client verbatim–except for one minor change in wording.  (Uncredited, of course).

I like to think it was such a great release that nothing needed to be done to it–or that perhaps my reputation for honesty was known. 

But, under my journalist’s hat, I was appalled that no one from AP called me or my client to confirm that we had actually sent the release–or checked the facts– before disseminating it to the world.

Today the situation is even more serious: anyone with a computer and an Internet  can post anything to the world. 

On the one hand, this great boon to free speech and the sharing of ideas and information.

But on the other, the burgeoning of Internet use has eroded the readership, financial position and  gatekeeping power of the traditional press. In financial distress,  news organizations are cutting corners–and staff. Reporters and editors are being asked to do more, faster.  

 Not only is there less coverage, but it is becoming more to difficult trust the accuracy of what is covered. The traditional press has long been our nation’s main bastion for protecting the marketplace of ideas from the spread of disinformation. 

I hope that media organizations, bloggers, anyone in a position to disseminate information will do so responsibly. And that my readers, business owners, the American public,  will subscribe, buy ads, do what you can–to prevent a potentially dangerous situation from getting worse.

Here’s a link to the Globe article:  http://www.boston.com/business/healthcare/articles/2010/06/23/cambridges_javelin_is_latest_target_of_hoax/

Anita M. Harris, president of the Harris Communications Group of Cambridge, MA, is a former national journalist who has taught journalism at Harvard, Yale and Tufts Universities and at Simmons College.

HarrisCom blog is a publication of the Harris Communications Group of Cambridge, MA. We also publish New Cambridge Observer and Ithaca Diaries.

I’m hard at work on Ithaca Diaries–a book, vook, and/or nook about college in the 1960s.I’m debating whether to go via the traditional publishing route (agent, publisher, an advance that will amount to about 2 cents an hour,  low royalties, do-it-yourself marketing, wait a year for it to come out)–or self-publish–which carries its own travails.

I’m interested to see that Amazon.com  is now offering self-published authors 75 percent of royalties on ebooks–compared with the measly 5 per cent I received for my first book, Broken Patterns–which came out in 1995 and for which I’m still paying back the $2000 advance. ( BTW–it’s now selling for 9 cents a copy on Amazon–plus postage; I now have the rights and will plan to offer a new edition later this year).

 I also note that Kindles are now being sold at Target for $279… though you can buy quite a few “real books” for that price,  pass them along to others,  and not worry that they’ll become useless as technology changes. 

Today’s Wall Street Journal   does a terrific job of exploring the ins and outs of self-publishing–and includes links to other excellent information.  

According to  Goffrey A. Fowler  and  Jeffrey A. Tractenberg:

 Much as blogs have bitten into the news business and YouTube has challenged television, digital self-publishing is creating a powerful new niche in books that’s threatening the traditional industry. Once derided as “vanity” titles by the publishing establishment, self-published books suddenly are able to thrive by circumventing the establishment. 

Here’s a link to the article:    Vanity Press Goes Digital 

–Anita M. Harris
HarrisCom Blog is a publication of the Harris Communications Group of Cambridge, MA. We also publish the New Cambridge Observer and Ithaca Diaries blogs.

A new review by my client, Scientia Advisors, finds that, with the market for biologic  drugs growing much faster than that of drugs based on chemical compounds, many biopharma companies are repositioning and forming new alliances in order to succeed in a rapidly changing pharmaceutical landscape.

In the review, released today, Scientia reports that revenue growth for the small molecule (chemically-based) drug segment has slowed and will begin to decline within three years as numerous blockbuster drugs go off patent and are replaced by less expensive generic substitutes.

In contrast, the market for biologics (based on living matter) which comprises approximately one-third of the overall pharmaceutical market, increased at a 21% compound annual growth rate (CAGR) between 2003 and 2008, to $110B.

While the CAGR for biologics has since slowed to 8%, Scientia projects 2013 revenues of $165B, due largely to rapid growth in monoclonal antibodies. Scientia also projects growth opportunities in the vaccine and cell therapy segments.

Many biologics command relatively high prices and require complex and expensive manufacturing processes. To keep costs down, biopharmaceutical companies are increasingly seeking to outsource their manufacturing to contract manufacturing organizations (CMOs).

 In addition, “numerous biologic therapies with total revenues of $37B will have lost patent protection by 2017, promising considerable opportunity in biosimilars (government-approved new versions of branded biopharmaceutical products following patent expiration),” Glorikian said. “As a result, pharmaceutical, generic drug, and contract manufacturing companies are joining forces to enter the biosimilars space. To be successful, they must take into account the considerable technical, competitive, and regulatory hurdles that will be involved.”

Scientia Advisors’ review, entitled “Assessing the Biopharmaceutical Market: Promises and Challenges,” is available for download at no charge from www.scientiaadv.com.

–Anita M. Harris

HarriscomBlog is a publication of the Harris Communications Group–a public relations, content and thought leadership firm in Cambridge, MA.  We also publish New Cambridge Observer.

A colleague asked me the other day if I think the field of media relations —in which public relations practitioners promote stories about their clients to the press—is  dead.  I don’t.  I believe it’s better now than it ever was.

It’s true that with the rise of Internet news, there are fewer traditional media outlets than in the past, and individual outlets are shrinking.There’s a smaller “news hole, “and, with social media responsibilities added to their reporting jobs, journalists are eeven busier now than  than they used to be.  

This means that  it’s increasingly difficult to get reporters’ attention–so that for media relations practitioners,  personal relationships and well-honed story ideas are key.

Still, just about every newspapers has an online presence, a 24-hour news cycle, bloggers, and links of its own—providing plenty of opportunity for companies and organizations to present news items that might, in pre-Internet days, have been overlooked.

Paid wire services—which I once avoided because reporters rarely picked up stories, there—now make press releases available online for  further dissemination by organizations, companies, trade media, bloggers, and twitterers—thus giving company news a presence all over the Web (and world).

Of course, media relations practice is  rapidly becoming ”social media relations”: journalists are increasingly  reporting stories and finding ideas based on information from blogs, twitter, facebook and the like—and social media campaigns sometimes become traditional print stories in themselves.

 In March, USA Today covered a Chevrolet tactic in which people filmed and shared, via smartphones,  their experiences driving cross-country (in Chevrolets, of course)  to an auto show.  (http://content.usatoday.com/communities/technologylive/post/2010/03/ford-gm/1     That tactic obviously worked big time: here I am, publicizing the article, Chevrolet, the trade show and USA Today, on my blog.

Whatever tactics you choose, it’s important to know your audience, provide accurate, well-written information –and maximize potential– through blogs, articles, white papers, links and SEO (search engine optimization). And don’t forget the possibilities using audio, visual, and other exciting new means.

I’m biased, but as far as I’m concerned, media relations is not just changing: it’s alive and well–and thriving.

These days, it’s no problem if that newspaper you slaved to get your client into gets used to wrap someone’s fish.

While the fast-changing Internet allows access to developments as they happen,  it also heightens our ability to store, search and share.  This means that (for better or worse) the information you put out stays out:  there’s no longer such a thing as yesterday’s news.

–Anita M. Harris
Anita M. Harris is the president of the Harris Communications Group, an award-winning public relations firm specializing in media relations, Internet content and social media. HarrisCom is based in Cambridge, MA.

A kazoo that records the air composition  in your lungs? Pill bottle caps that tell your doctor if you’ve take your medication?  A headband that measures how well you sleep? A gadget that relays your blood sugar  level to your doctor’s office—through your Smart Phone? Those are just a few of the new devices in the growing field of “local health monitoring” —through  which people can keep track of their own health conditions without setting foot in a hospital or doctor’s office.

Those gadgets—and others—were described at a recent panel discussion sponsored by the Medical Development Group, a Boston area organization for individuals involved  in medical technologies.

Frank McGillin, Vice President of Global Marketing for Philips Healthcare, which markets a variety of home monitoring devices, emphasized the importance these devices in light of growing health care costs.

He cited government statistics showing that  health care current accounts for 17.6 percent of the  gross domestic product in the US, and that by 2050, half of the population in the developed world will be chronically ill—making traditional medical care  fiscally overwhelming. 

Monitoring devices and telemedicine are already used for coaching patients remotely–and monitoring may also soon be available to determine measuring cancer patients’ readiness for—and the effectiveness of—chemotherapy—from home.

Ben Rubin, Co-Founder and Chief Technology officer of Zeo, in Newton, MA, described a headset and device that monitor an individual’s REM sleep and factors influencing sleep patterns.  Knowing how well you sleep is important because sleep is closely tied to health conditions like obesity, depression, diabetes and the like, Rubin said. “If you measure it, you can manage it.” 

The devices, which cost $250,  connect to  an Internet site. For an additional $100, ZEO provides email advice coaching to help individuals improve their “sleep hygiene.” 

 I’ve since learned of a Smart Phone application designed to promote better sleep:  using the Ap, you put your phone under your pillow to measure your movement (and restlessness) during sleep.

David Rose, Chief Executive officer of Vitality, Inc., in Cambridge, MA—explained that the above-mentioned pill bottle “glo-caps” can “ sense”  when a patient takes a medication, and, via a wireless Internet connection, show health care professionals whether reminder calls should be made. The caps illuminate, play a melody, and even ring a home phone to remind patients to take their pills.  The caps can send weekly emails to remote caregivers, create accountability with doctors through an adherence report, and automatically refill prescriptions. 

Glo-Caps are not currently available for purchase by individuals, but they are being used by patients enrolled in programs sponsored by certain health insurers and pharmacies.

Rose, who teaches at the Massachusetts Institute of Technology, previously founded and ran Ambient Devices, where he pioneered embedding monitoring devices in everyday objects such as:   umbrellas that can sense if it is going to rain; bathroom scales showing trend lines for weight-loss or gain; objects that measure air quality; a spirometer “kazoo” that measures the chemistry of air expelled from the lungs, and a telephone that uses an individual’s vocal qualities to measure depression. 

Devorah Klein, PhD, a principal at Continuum, in Newton, MA, designs and studies the effectiveness of self-monitoring and other devices. 

 An expert in patient adherence to therapy regimes for diabetes, asthma, arthritis, multiple sclerosis and erectile dysfunction, she described the importance of understanding how users interact with devices. Simple designs are key because “many patients are not all that interested” in devices— learning how  to use them, or how they work.

Panelists also described use of  Internet tools such as Google to measure flu trends; Healthmedia, through which Johnson & Johnson provides digital coaching for managing stress and chronic disease, Philips Direct, which provides live coaching over email, and various “calorie and other body monitors through which individuals can receive online coaching through gyms

David Barash, MD, president of Concord Healthcare Strategies and the panel moderator, pointed out that local monitoring devices are growing in popularity in sync with an aging population, increasing chronic disease, and new Internet technologies. 

According to a recent review by my client, Scientia Advisors, remote home monitoring, with a market size of 1.8B in 2007,  is growing at a combined annual growth rate of 15% per year–which makes remote monitoring  the fastest growing segment in a home health industry projected to reach $200B by 2012.

However, Barash said,  business models for many remote or local  monitoring products are, as yet, unproved.

One problem  is that, in the absence of adequate clinical trials, insurance reimbursement is limited, which makes doctors reluctant to adopt remote monitoring, Scientia found.

There are also questions about how doctors will be able to handle potentially huge quantities of data, potential liability issues,  Barash said, and  about the usefulness of  data from a myriad of individual monitors—when so many health conditions are interconnected. 

 “It’s very important for companies to ask, ‘Do people want this device? Will they use it?’” Barash said.

After the meeting, I mentioned to an  MDG board member that I don’t want all of this surveillance. “I’m just not that interested in my bodily functions,” I said.
“Just wait ten years,” she assured me.  “You will be.”

—Anita M. Harris

Anita M. Harris is the founder and president of the Harris Communications Group, a public relations firm in Cambridge, MA.  HarrisCom publishes the HarrisCom Blog and New Cambridge Observer

All rights reserved; please email us at info at harriscom.com for permission to use or reprint this material. Thanks!  

I’m very pleased to announce that the Harris Communications Group is now located at 1 Broadway, on the 14th floor of the esteemed Cambridge Innovation Center.

The CIC, founded in 1999, offers shared or dedicated space to some 250 startups and emerging companies–in an atmosphere of co-operation and positive energy. (Those are my words, not the CIC’s!)

My first day at the CIC, I met at least 10 people; now two weeks in, I’ve attended three “VC Cafes,” which are social events, open to CIC members and the public, at which venture capitalists are available, by appointment, to discuss funding opportunities. 

VC Cafe 4-15-10

I’ve also met Internet entrepreneur Costas Boussios; clinical trial designer Candida Fratazzi, MD , president of Boston Biotech Clinical Research; CIC founder Tim   Rowe ,  and a gentleman from another CIC floor whose name I did not catch but who advised me, in the 14th floor snack area, to stay away from the yogurt because it has high sugar content–then indulged in some,  himself.

14th floor snack area

 

Brenda Steinberg and Candida Fratazzi, of the CIC Women Innovators Network

On Thursday, I was invited to speak about blogging at a May meeting sponsored by the CIC Women Innovators Network (WIN), which will be open to everyone at the CIC.

Nicole, the concierge, whose last name I need to get.

I’m about to head over  now; can’t wait to see what the new week will bring!  

—–Anita M. Harris
 

 

 

HarrisCom blog is a publication of the Harris Communications Group of Cambridge, MA. We also publish the New Cambridge Observer and Ithaca Diaries blogs.

Follow

Get every new post delivered to your Inbox.